收藏切换
Mechanisms of eleutheroside for treatment of diabetes mellitus type 2 based on network pharmacology
收藏切换
PDF
Wen-bin YUAN, Yan-mei WEI, Yong CHEN*, Ji-chao LIANG*
Acta Pharmaceutica Sinica | 2019, 54(11) : 1982 - 1989
Less
收藏切换
Acta Pharmaceutica Sinica | 2019, 54(11): 1982-1989
Original Articles
Mechanisms of eleutheroside for treatment of diabetes mellitus type 2 based on network pharmacology
Full
Wen-bin YUAN, Yan-mei WEI, Yong CHEN*, Ji-chao LIANG*
Affiliations
  • Hubei Province Key Laboratory of Biotechnology of Chinese Traditional Medicine, National and Local Joint Engineering Research Center of High-throughput Drug Screening Technology, Hubei University, Wuhan 430062, China
Published: 2019-11-12 doi: 10.16438/j.0513-4870.2019-0350
Outline
收藏切换

Seven main components in eleutheroside were used as research objects, and the mechanism of action of total eleutheroside for treatment of diabetes mellitus type 2 was investigated by network pharmacology. The SwissTargetPrediction, GeneCard, and String platforms were used to predict the 35 potential targets of these 7 components that are related to diabetes mellitus type 2. Then we used cytoscape 3.6.1 to build a " component-target" network map and used the Networkanalyzer tool for topology analysis. Gene ontology (GO) enrichment analysis and KEGG pathway enrichment analysis were performed on the DAVID6.8 platform, and the " component-target-path" network map was constructed based on the enrichment results. Those components mainly used in diabetes mellitus type 2 were screened as core components, and the core components were docked with key disease target proteins to verify the potential mechanism of the total eleutheroside. After screening, 8 important pathways associated with diabetes mellitus type 2 were identified. This study showed that eleutheroside A, eleutheroside D, eleutheroside E and sesamin played key roles in insulin resistance, apoptosis and inflammation pathways. The total eleutheroside may ameliorate type 2 diabetes mainly through regulating signal transducer and activator of transcription factors (STATs), non-receptor protein tyrosine phosphatase (PTPN) 1, PTPN2, c-Jun N-terminal kinase (JNK), and p38 mitogen activate protein kinase. These components worked together through multiple signaling pathway. Based on our data, eleutheroside is proposed as a novel therapeutic strategy for treatment of type 2 diabetes.

network pharmacology  /  eleutheroside  /  diabetes mellitus type 2  /  mechanism  /  target
Wen-bin YUAN, Yan-mei WEI, Yong CHEN, Ji-chao LIANG. Mechanisms of eleutheroside for treatment of diabetes mellitus type 2 based on network pharmacology[J]. Acta Pharmaceutica Sinica, 2019 , 54 (11) : 1982 -1989 . DOI: 10.16438/j.0513-4870.2019-0350
Year 2019 volume 54 Issue 11
PDF
139
52
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2019-0350
  • Receive Date:2019-05-05
  • Online Date:2026-01-26
  • Published:2019-11-12
Article Data
Affiliations
History
  • Received:2019-05-05
  • Revised:2019-07-10
Funding
Affiliations
    Hubei Province Key Laboratory of Biotechnology of Chinese Traditional Medicine, National and Local Joint Engineering Research Center of High-throughput Drug Screening Technology, Hubei University, Wuhan 430062, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2019-0350
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT